WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amir WeissChief Accounting Officer2025-12-1612,300$30.20
$371.51kSell
Roberto MignoneDirector2025-12-1677,400$30.24
$2.34MSell
Mark SabagSee Remarks2025-12-0998,168$28.70
$2.82MSell
Richard DaniellExec. VP European Commercial2025-12-09100,457$18.61
$1.87MBuy
Richard DaniellExec. VP European Commercial2025-12-0915,011$16.99
$255.04kBuy
Richard DaniellExec. VP European Commercial2025-12-09115,468$28.68
$3.31MSell
Mark SabagSee Remarks2025-12-09118,724$18.61
$2.21MBuy
Mark SabagSee Remarks2025-12-09118,724$28.75
$3.41MSell
Roberto MignoneDirector2025-11-2650,000$26.03
$1.30MSell
Christine FoxEVP Head of U.S. Commercial2025-11-2028,229$24.78
$699.51kSell

1 of 5

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TEVA insiders and whales buy or sell their stock.

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc5.04%57,802,408$1.74BInstitution
Phoenix Financial Ltd3.60%41,295,244$1.24BInstitution
Menora Mivtachim Holdings Ltd3.39%38,920,294$1.17BInstitution
Harel Insurance Investments Financial Services Ltd3.29%37,696,690$1.13BInstitution
Migdal Insurance Financial Holdings Ltd2.84%32,582,212$979.42MInstitution
Clal Insurance Enterprises Holdings Ltd2.74%31,486,683$946.49MInstitution
Lingotto Investment Management LLP2.49%28,588,790$859.38MInstitution
Rubric Capital Management LP2.15%24,650,000$740.98MInstitution
Fmr LLC2.15%24,641,362$740.72MInstitution
Pointstate Capital LP1.81%20,712,398$622.61MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA57.27%0.75%Net SellingNet Selling
HLN6.19%0.00%
TAK5.35%0.00%
ZTS92.83%5.85%Net SellingNet Selling
NBIX70.78%29.22%Net SellingNet Buying
View Top Pharmaceutical Stocks

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 57.27% institutional shareholders, 0.75% Teva Pharmaceutical Industries insiders, and 41.98% retail investors. Blackrock Inc is the largest individual Teva Pharmaceutical Industries shareholder, owning 57.80M shares representing 5.04% of the company. Blackrock Inc's Teva Pharmaceutical Industries shares are currently valued at $1.75B.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.